Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial
Titel:
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial
Auteur:
Grob, Jean Jacques Amonkar, Mayur M Karaszewska, Boguslawa Schachter, Jacob Dummer, Reinhard Mackiewicz, Andrzej Stroyakovskiy, Daniil Drucis, Kamil Grange, Florent Chiarion-Sileni, Vanna Rutkowski, Piotr Lichinitser, Mikhail Levchenko, Evgeny Wolter, Pascal Hauschild, Axel Long, Georgina V Nathan, Paul Ribas, Antoni Flaherty, Keith Sun, Peng Legos, Jeffrey J McDowell, Diane Opatt Mookerjee, Bijoyesh Schadendorf, Dirk Robert, Caroline